Abu Dhabi Campus
Dr. Rose Ghemrawi is the Director of the AAU Health and Biomedical Research Center at Al Ain University in Abu Dhabi, UAE, a position she has held since January 2022. In this role, she has spearheaded the establishment and growth of a state-of-the-art biomedical research center focused on innovative health solutions. Since September 2017, she has also served as an Associate/Assistant Professor in Biochemistry and Molecular Biology at Al Ain University, where she has conducted and led research on cancer, earning acclaim for her teaching excellence in undergraduate and graduate courses.
Prior to this, Dr. Ghemrawi was a Postdoctoral Researcher at McGill University in Montreal, Canada, from August 2016 to August 2017, where she studied the effects of body mass index, folate, homocysteine, and genetic polymorphisms on fertility parameters and the sperm epigenome. Her earlier postdoctoral work at the ‘Nutrition, Genetics and Environmental Risk Exposure’ Laboratory in Nancy, France, from October 2013 to April 2016, focused on B12 metabolism and its implications for neurodegeneration and metabolic diseases.
Dr. Ghemrawi's educational background includes a PhD in Life and Health Sciences from Lorraine University, France, where her dissertation examined the impact of Vitamin B12 deficiency on cellular stress mechanisms, a Research Master 2 in Biology and Health, a Master 1 in Biochemistry and Molecular Biology from Lorraine University, France, and a Bachelor in Biochemistry from Lebanese University.
Dr. Rose Ghemrawi’s research interests lie at the intersection of biochemistry, molecular biology, and biomedical engineering, with a particular focus on the molecular mechanisms underlying cancer and metabolic diseases. Her work aims to unravel the complex pathways involved in cellular stress responses, nutrient metabolism, and genetic polymorphisms. Her research also delves into the impact of nutritional factors on gene expression and disease progression, seeking to integrate dietary interventions with molecular therapies.
Effects of subcutaneous vs. oral nanoparticle-mediated insulin delivery on hemostasis disorders in type 1 diabetes: A rat model study. Kaddour N, Benyettou F, Moulai K, Mebarki A, Allal-Taouli K, Ghemrawi R, Whelan J, Merzouk H, Trabolsi A, Mokhtari-Soulimane NA. Heliyon, 2024.
Extended Reality Head-Mounted Displays Are Likely to Pose a Significant Risk in Medical Settings While Current Classification Remains as Non-critical. Goldsworthy A, Olsen M, Koh A, Demaneuf T, Singh G, Almheiri R, Chapman B, Almazrouei S, Ghemrawi R, Senok A, McKirdy S, Alghafri R, Tajouri L. Microorganisms, 2024
Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance. Mousa W, Mousa S, Ghemrawi R, Obaid D, Sarfraz M, Chehadeh F, Husband S. International Journal of Molecular Sciences, 2023
Do mobile phone surfaces carry SARS-CoV-2 virus? A systematic review warranting the inclusion of a “6th” moment of hand hygiene in healthcare. Olsen M, Demaneuf T, Singh G, Goldsworthy A, Jones P, Morgan M, Nassar R, Senok A, Ghemrawi R, Almheiri R, Al Marzooqi H, Almansoori S, Albastaki A, Almansoori R, McKirdy R, Alghafri R, Tajouri L, Journal of Infection and Public Health, 2023
DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy. Ghemrawi R, Al Qassem A, Ramadan A, Aldulaymi R, Sammani N, Mousa W, Khair M. PloS one, 2023
Discovery of Lactomodulin, a Unique Microbiome-Derived Peptide That Exhibits Dual Anti-Inflammatory and Antimicrobial Activity against Multidrug-Resistant Pathogens. Mousa W, Ghemrawi R, Abu-Izneid T, Ramadan A, Al-Marzooq F. International Journal of Molecular Sciences, 2023
Mobile Phones: Reservoirs of Resistant Bacteria during the COVID-19 Pandemic in Abu Dhabi, United Arab Emirates. Kayed K, Khoder G, Farhat J, Ghemrawi R. Microorganisms, 2023
Molecular Modelling Study and Antibacterial Evaluation of Diphenylmethane Derivatives as Potential FabI Inhibitors. Hasan S, Kayed K, Ghemrawi R, Al Bataineh N, Mahgoub R, Audeh R, Aldulaymi R, Atatreh N, Ghattas MA. Molecules, 2023
Are we aware of stroke risk factors and warning signs amid COVID-19? Knowledge and attitude towards risk-factors, signs and symptoms of stroke among the UAE population during COVID-19 pandemic: A cross-sectional study. Ramadan A, Kharaba Z, Ghemrawi R, Elnour A, Hussain N, Kouhgard P, Al-Damook N, Abou Hait S, Al Ghanem L, Atassi R, Chkh Sobeh R, Al Meslamani A. F1000Research, 2023
Expired Medications and Disposal Practices in Arab households. Ghemrawi R, Alghaly F, Qassem N, Kharaba Z, Albataineh N, Aldulaymi R, Khair M. International Journal of Pharmacy Practice, 2022
Pharmaceutical Biotechnology (Master students), Biology, Microbiology and Immunology, Science and Life, Biochemistry and Biotechnology, Pharmacogenomics, Organic chemistry lab, Analytical chemistry lab, Anatomy and Physiology lab, Biostatistics, Nutrition, Enzymology, Energetic expenses, Ergonomics.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all.
This person’s work contributes towards the following SDG(s):
Member of the Canadian DOHaD Society.
Member of the Organization for the Study of Sex Differences.
Member of the Centre for Research in Reproduction and Development.
Copyright © 2024 Al Ain University. All Rights Reserved.